Compare CYTK & EDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | EDU |
|---|---|---|
| Founded | 1997 | 1993 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.0B |
| IPO Year | 2004 | 2006 |
| Metric | CYTK | EDU |
|---|---|---|
| Price | $63.34 | $60.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $84.81 | $62.80 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 02-26-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | N/A | ★ 3.94 |
| EPS | N/A | ★ 2.38 |
| Revenue | $87,211,000.00 | ★ $5,140,631,000.00 |
| Revenue This Year | $341.94 | $10.91 |
| Revenue Next Year | $75.44 | $10.38 |
| P/E Ratio | ★ N/A | $25.33 |
| Revenue Growth | ★ 2609.26 | 6.70 |
| 52 Week Low | $29.31 | $40.66 |
| 52 Week High | $70.98 | $63.78 |
| Indicator | CYTK | EDU |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 63.87 |
| Support Level | $62.13 | $55.04 |
| Resistance Level | $65.88 | $63.78 |
| Average True Range (ATR) | 2.59 | 1.86 |
| MACD | 0.07 | 0.30 |
| Stochastic Oscillator | 54.84 | 66.53 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.